Stay updated on Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.

Latest updates to the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange Detected- Added a new history entry for Revision: v3.4.3 and removed the previous entry for Revision: v3.4.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision label v3.4.2 appears in the study record history, replacing the previous v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe Record History shows a minor version update from v3.4.0 to v3.4.1 with no user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedShow glossary option added; color-coded highlights for additions (green) and deletions (red) in the record history, and the revision label updated to v3.4.0.SummaryDifference1%

- Check61 days agoChange DetectedThe record history now shows a new revision (v3.3.4) and the previous v3.3.3 entry has been removed, updating the version history without changing trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.3.3. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

Stay in the know with updates to Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.